The U.S. Market for Rx to OTC Switches, 6th Edition
1/11/2013 | published by: Kalorama Information
... Kalorama Information has analyzed the market for drugs with switched ingredients in detail. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes ...
|
more...
|
$3,995.00
|
OTC Medications – US – a snapshot (2012)
1/2/2013 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in US is given in USD with a minimum ...
|
more...
|
$600.00
|
Vitamins & Minerals – US – a snapshot (2012)
12/28/2012 | published by: Mintel - Snapshots
... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in US is given in USD with a minimum of five years' ...
|
more...
|
$600.00
|
Canada Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... also experienced governmentcost containment policies and the patent cliff in Canada, the negative impact of these phenomena is lessextreme than that in many other developed countries. The average cost of generic drugs per prescriptionexperienced its ...
|
more...
|
$1,175.00
|
Vitamins & Minerals – Canada – a snapshot (2012)
12/20/2012 | published by: Mintel - Snapshots
... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Canada is given in CAD with a minimum of five years' ...
|
more...
|
$600.00
|
Biotechnology Product Manufacturing
12/17/2012 | published by: First Research, Inc.
... Genentech (owned by Switzerland-based Roche), and Monsanto; Cangene (Canada) and ADIMMUNE (Taiwan); and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). The global biotechnology industry includes about 7,000 companies with ...
|
more...
|
$129.00
|
|
|
$149.00
|
U.S. Life Science 2013 Top 10 Predictions
12/5/2012 | published by: IDC
... actively embracing technological innovation and cross-industry best practices as it continues its quest to regain long-term sustainability. Leading life science companies and their supporting vendor ecosystem are aligned as they both seek to move the ...
|
more...
|
$4,500.00
|
|
|
$2,995.00
|
|
|
$4,995.00
|
|
|
$2,500.00
|
|
|
$4,995.00
|
Pharmaceuticals - North America (NAFTA) Industry Guide
11/30/2012 | published by: MarketLine
... The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. Scope of the ...
|
more...
|
$795.00
|
Pharmaceuticals in Mexico
11/21/2012 | published by: MarketLine
... metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies ...
|
more...
|
$350.00
|
Pharmaceuticals in Canada
11/21/2012 | published by: MarketLine
... metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies ...
|
more...
|
$350.00
|
Pharmaceuticals in the United States
11/21/2012 | published by: MarketLine
... key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth ...
|
more...
|
$350.00
|
|
|
$6,995.00
|
Packaging Services in USA: ISIC 7495
11/13/2012 | published by: Euromonitor International
... provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they ...
|
more...
|
$600.00
|
Health Supplement Stores
11/12/2012 | published by: First Research, Inc.
... industry includes 5,000 companies operating about 10,000 stores with combined annual revenue of about $6 billion. US personal consumption for drug preparations and sundries, a major indicator for health supplement stores, is forecast to grow ...
|
more...
|
$129.00
|
Kidney Dialysis Centers
11/12/2012 | published by: First Research, Inc.
... US commercial kidney dialysis industry includes about 4,200 centers with combined annual revenue of about $16 billion. High growth is forecast for this industry for the next two years. Key drivers for demand include the ...
|
more...
|
$129.00
|
US Cardiovascular Surgery Market Trends Forecast To 2018
11/7/2012 | published by: ABMRG
... (BHS) Cardiac Ablation Devices Cardiopulmonary Bypass Equipment Perfusion Disposables Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights ...
|
more...
|
$2,100.00
|
|
|
$2,100.00
|
|
|
$10,000.00
|
US Prenatal Testing Market Report: 2012 Edition
11/1/2012 | published by: Koncept Analytics
... issues emanating from the changing lifestyle and continuously changing surroundings. To address the growing demand for better diagnosis and treatment options and the unmet needs within the chromosomal abnormalities and genetic disorders segment, respective companies ...
|
more...
|
$800.00
|
US Pharmaceutical Industry – PEST Framework Analysis
11/1/2012 | published by: Aruvian's R'search
... solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market. The US continues to generate the ...
|
more...
|
$200.00
|